While Europe enjoys cheap biotech drugs, U.S. waits on FDA – Forbes
While the U.S. government works out final regulations to bring cheaper copies of expensive drugs derived from biotechnology to patients here ... not part of the landmark 1984 Hatch-Waxman law, which cleared a regulatory path for cheaper generic ...
Subscribe to LegalLaw247.Com Newsletter
